We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRNT icon
751
Kornit Digital
KRNT
$708M
$270K 0.03%
10,460
-13,838
-57% -$255K
HTLD icon
752
Heartland Express
HTLD
$1.04B
$270K 0.03%
22,004
-18,343
-45% -$225K
ALLE icon
753
Allegion
ALLE
$13.7B
$269K 0.03%
+1,844
New +$244K
PDFS icon
754
PDF Solutions
PDFS
$1.87B
$268K 0.03%
8,460
-4,053
-32% -$132K
UFPI icon
755
UFP Industries
UFPI
$5.14B
$268K 0.03%
2,040
-313
-13% -$37.8K
WSO icon
756
Watsco Inc
WSO
$15.1B
$267K 0.03%
+542
New +$261K
UBS icon
757
UBS Group
UBS
$171B
$264K 0.03%
+8,535
New +$256K
INGR icon
758
Ingredion
INGR
$6.48B
$261K 0.03%
+1,901
New +$242K
SEM
759
DELISTED
Select Medical
SEM
$260K 0.03%
13,829
-17,148
-55% -$329K
PBH icon
760
Prestige Consumer Healthcare
PBH
$2.45B
$259K 0.03%
+3,592
New +$254K
GCMG icon
761
GCM Grosvenor
GCMG
$745M
$259K 0.03%
+22,877
New +$246K
MATW icon
762
Matthews International
MATW
$900M
$259K 0.03%
11,147
+542
+5% +$13.7K
CSX icon
763
CSX Corp
CSX
$94.2B
$258K 0.03%
7,485
-15,474
-67% -$525K
ETSY icon
764
Etsy
ETSY
$8.21B
$257K 0.03%
+4,623
New +$262K
LAND
765
Gladstone Land Corp
LAND
$366M
$256K 0.03%
18,436
-739
-4% -$10.4K
OLN icon
766
Olin
OLN
$2.44B
$255K 0.03%
5,309
-29,455
-85% -$1.31M
AIR icon
767
AAR Corp
AIR
$5.62B
$253K 0.03%
+3,870
New +$256K
ARKO icon
768
ARKO Corp
ARKO
$901M
$253K 0.03%
35,977
-7,327
-17% -$46.3K
APOG icon
769
Apogee Enterprises
APOG
$873M
$252K 0.03%
+3,606
New +$232K
PGRE
770
DELISTED
Paramount Group
PGRE
$252K 0.03%
51,241
+35,315
+222% +$175K
INTA icon
771
Intapp
INTA
$2.36B
$250K 0.03%
5,237
-1,882
-26% -$75.9K
HAL icon
772
Halliburton
HAL
$26.1B
$249K 0.03%
8,575
-21,889
-72% -$690K
NX icon
773
Quanex
NX
$893M
$249K 0.03%
+8,963
New +$255K
CACI icon
774
CACI
CACI
$11.3B
$247K 0.03%
+490
New +$227K
VICI icon
775
VICI Properties
VICI
$29.8B
$247K 0.03%
7,417
-11,092
-60% -$351K
29 30
31
32 33

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.